Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.
van Slooten HJ, van De Vijver MJ, Borresen AL, Eyfjörd JE, Valgardsdóttir R, Scherneck S, Nesland JM, Devilee P, Cornelisse CJ, van Dierendonck JH. van Slooten HJ, et al. Among authors: van dierendonck jh, van de vijver mj. J Pathol. 1999 Dec;189(4):504-13. doi: 10.1002/(SICI)1096-9896(199912)189:4<504::AID-PATH483>3.0.CO;2-A. J Pathol. 1999. PMID: 10629550
Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.
van Slooten HJ, Clahsen PC, van Dierendonck JH, Duval C, Pallud C, Mandard AM, Delobelle-Deroide A, van de Velde CJ, van de Vijver MJ. van Slooten HJ, et al. Among authors: van dierendonck jh, van de vijver mj, van de velde cj. Br J Cancer. 1996 Jul;74(1):78-85. doi: 10.1038/bjc.1996.319. Br J Cancer. 1996. PMID: 8679463 Free PMC article. Clinical Trial.
High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.
Elkhuizen PH, van Slooten HJ, Clahsen PC, Hermans J, van de Velde CJ, van den Broek LC, van de Vijver MJ. Elkhuizen PH, et al. Among authors: van slooten hj, van de vijver mj, van de velde cj, van den broek lc. J Clin Oncol. 2000 Mar;18(5):1075-83. doi: 10.1200/JCO.2000.18.5.1075. J Clin Oncol. 2000. PMID: 10694560 Clinical Trial.
Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice.
Steeghs EMP, Vink GR, Elferink MAG, Voorham QJM, Gelderblom H, Nagtegaal ID; PATH Consortium Members; Grünberg K, Ligtenberg MJL; PATH consortium members. Steeghs EMP, et al. J Clin Pathol. 2021 Oct 21;75(10):706-11. doi: 10.1136/jclinpath-2021-207865. Online ahead of print. J Clin Pathol. 2021. PMID: 34675090 Free PMC article.
Receptor conversion in distant breast cancer metastases.
Hoefnagel LD, van de Vijver MJ, van Slooten HJ, Wesseling P, Wesseling J, Westenend PJ, Bart J, Seldenrijk CA, Nagtegaal ID, Oudejans J, van der Valk P, van der Groep P, de Vries EG, van der Wall E, van Diest PJ. Hoefnagel LD, et al. Among authors: van der groep p, van der valk p, van der wall e, van slooten hj, van de vijver mj, van diest pj. Breast Cancer Res. 2010;12(5):R75. doi: 10.1186/bcr2645. Epub 2010 Sep 23. Breast Cancer Res. 2010. PMID: 20863372 Free PMC article.
38 results